Sigal Charles Elliott
Vir Biotechnology, Inc. · Director
Sigal Charles Elliott is listed in filings as Director at Vir Biotechnology, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including 6 public disclosures. Recent filings connect the profile to Vir Biotechnology, Inc. (VIR) and Alnylam Pharmaceuticals Inc (ALNY). The current snapshot covers public activity from Jun 2, 2025 to May 28, 2026. Reported amounts are shown as $145.6K to $79.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||